BackInnovations
Sciences
Orion Innovations, Inc. is a healthcare company with a commercially launched, revenue-generating portfolio of single-use, smart, simple, disposables. At Orion Innovations, we focus on new and disruptive technologies that improve patient safety for the highest quality outcomes. Grounded in the principle that robust solutions can be simple to adopt, we think about caregivers and facilities, and how we can streamline the best possible patient experience through healthcare heroes.
The Products:
The MedLite ID Smart-Lite system identifies & illuminates infusion lines in seconds, helping prevent life-threatening infusion Adverse Drug Events.
NoGag oral care made Smart, Simple, Stress-Free. 10 Seconds to eliminate the gag reflex and increase referrals, procedures, and patients.
OxySwitch is a disposable oxygen valve that allows caregivers to switch seamlessly between oxygen delivery devices.
RODNEY W. SCHUTT
Rodney Schutt is a proven multiple-time President and CEO of publicly traded, privately held, venture capital and private equity-backed companies.
He has led several companies in the healthcare industry, including HyperSound with directed audio emitter technology, Widex and Unitron who both develop hearing solutions, and Aspyra with clinical software. He also led Luminetx with their development of the VeinViewer, a mobile device used to locate a patient’s vasculature. Previously, Rodney held Senior Executive positions within Smith & Nephew Orthopaedics. He started his career at GE Healthcare, where he spent 18 plus years growing in the organization and eventually serving in Senior Executive roles.
This broad range of leadership experience has provided Rodney with a well-rounded and intuitive appreciation of operations, sales, marketing, business development, and management skills, as well as a deep understanding of the healthcare industry.
MICHAEL CARSON
Mr. Michael Carson has over 20 years of broad experience in corporate finance, accounting, and sales operations, with over 17 years in medical device, biotechnology, and biopharmaceutical sectors. Additionally, Mike has enjoyed a career in several finance, accounting, sales operations, and treasury roles across several stage companies, including private commercial, and publicly traded companies.
Recently Mike consulted for Standard Bariatrics during their $300 million exit to Teleflex and has previous experience at Xylocor Therapeutics, Smiths Medical, which was acquired by ICU medical in January 2022, Neuronetics (NASDAQ: STIM), and Abbott Laboratories (NYSE: ABT), and served as an auditor at Crowe Chizek and Deloitte. Mike has raised over $50 million in funds for companies through several vehicles, including stock sales, convertible notes, and PIPEs.
Received a Bachelor of Arts in Business and Economics along with a Bachelor of Science in Mechanical Engineering from Lafayette College in Pennsylvania. He is a licensed Certified Public Accountant in the Commonwealth of Pennsylvania.
CHRIS SCHNEE
Chris is a commercial leader within startups through Fortune 50 public and private companies, creating growth throughout the business life cycle with extensive global depth. Emphasis on novel, disruptive, emerging, and high-performance solutions has grown to standard-of-care adoption.
22 years of healthcare commercial leadership, sales, marketing, and business operations experience within the medical device, acute-healthcare AI SaaS, and medical imaging.
Before joining MedLite ID, Chris served as CCO at MaxQ AI. Additional roles earlier in his career included VP Sales & Marketing at Centurion and General Manager at Christie Medical. Earlier commercial leadership roles included Smith and Nephew, Healthtronics, and GE Healthcare. Before healthcare, Chris served within the semiconductor and polymer films industries for several years.